7-week Study With CT-155 in People With Schizophrenia
Public ClinicalTrials.gov record NCT05486312. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of Treatment With CT-155 in People With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
CT-155 is a novel prescription digital therapeutic (PDT) to treat schizophrenia
Study identification
- NCT ID
- NCT05486312
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2022 (Actual)
- Primary completion
- Sep 22, 2022 (Actual)
- Completion
- Dec 12, 2022 (Actual)
- Last update posted
- May 15, 2025
2022
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CT-155 Study Center | Culver City | California | 90230 | — |
| CT-155 Study Center | Garden Grove | California | 92845 | — |
| CT-155 Study Center | La Habra | California | 90631 | — |
| CT-155 Study Center | San Bernardino | California | 92408 | — |
| CT-155 Study Center | Santa Ana | California | 92704 | — |
| CT-155 Study Center | Chicago | Illinois | 60611 | — |
| CT-155 Study Center | New York | New York | 10032 | — |
| CT-155 study Center | Staten Island | New York | 10314 | — |
| CT-155 Study Center | Beachwood | Ohio | 44122 | — |
| CT-155 Study Center | Oklahoma City | Oklahoma | 73112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05486312, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2025 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05486312 live on ClinicalTrials.gov.